Preimplantation Genetic Diagnosis is a process that is used prior to implantation for helping in identifying of genetic defects within an embryo. This serves to prevent certain genetic diseases or disorders from being passed on to the child.
MARKET DYNAMICS
The Preimplantation Genetic Diagnosis market is anticipated to grow in the forecast, owing to the factors such as growing prevalence of genetic, hereditary and chromosomal diseases, rising rates in birth defects, increasing awareness among the population regarding prevention of genetic diseases, increasing awareness about reproductive health, high demand of in vitro fertilization treatments and advancements in the PGF availing diagnosis of disease such as cancer. Nevertheless, ethical issues related to sex determination and strict regulations is expected to restrict the market growth during the forecast period.
MARKET SCOPE
The "Global Preimplantation Genetic Diagnosis Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Preimplantation Genetic Diagnosis market with detailed market segmentation by Test and geography. The global Preimplantation Genetic Diagnosis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Preimplantation Genetic Diagnosis market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Preimplantation Genetic Diagnosis market is segmented on the basis of Type. Based on type the market is segmented into Chromosomal Abnormalities, Aneuploidy, X-linked Diseases, Single Gene Disorders, HLA Typing, Gender selection, Others.
(image)
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Preimplantation Genetic Diagnosis market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Preimplantation Genetic Diagnosis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Preimplantation Genetic Diagnosis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Preimplantation Genetic Diagnosis market in these regions.
(image)
MARKET PLAYERSThe reports cover key developments in the Preimplantation Genetic Diagnosis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Preimplantation Genetic Diagnosis market are anticipated to lucrative growth opportunities in the future with the rising demand for Preimplantation Genetic Diagnosis market in the global market. Below mentioned is the list of few companies engaged in the Preimplantation Genetic Diagnosis market.
The report also includes the profiles of Preimplantation Genetic Diagnosis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-Quest Diagnostics Inc.
-Genesis Genetics Ltd
-Reproductive Genetics Innovations LLC
-Laboratory Corporation of America Holdings
-Natera, Inc
-PerkinElmer, Inc
-Reprogenetics, LLC.
-Genea Limited
-F. Hoffmann-La Roche AG
-Illumina, Inc
(image)